Minerva NeurosciencesNERV
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 30 institutions reported holding Minerva Neurosciences Inc. (NERV) in their 13F filings, up 8 from Q3 2025. 12 opened new positions and 6 sold out. The largest holders were Federated Hermes, Inc. ($19.5M), Vivo Capital, LLC ($17.4M) and Janus Henderson Group PLC ($17.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Minerva Neurosciences Inc.
- CUSIP
- 603380205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $79.1M |
| Exits | 6 | $48K |
All 13F filers, Q3 2025 → Q4 2025: 19,473,552 shares bought and 36,318 shares sold, net +19,437,234 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Federated Hermes, Inc. | 0.03% | Add +297.5% | 5,371,775 | $19.5M |
| Vivo Capital, LLC | 1.12% | New | 4,322,747 | $17.4M |
| Janus Henderson Group PLC | 0.01% | New | 9,000 | $17.1M |
| Logos Global Management LP | 0.89% | New | 3,311,000 | $13.3M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | New | 2,838,000 | $11.4M |
| Farallon Capital Management, L.L.C. | 0.05% | New | 2,365,000 | $9.5M |
| Ally Bridge Group (NY) LLC | 10.56% | New | 1,655,500 | $6.7M |
| Spruce Street Capital LP | 2.20% | — | 1,655,500 | $6.7M |
| Acuta Capital Partners, LLC | 1.94% | New | 709,500 | $2.9M |
| Vanguard Group Inc. | 0.00% | No change | 252,029 | $1.0M |
| Renaissance Technologies | 0.00% | Add +28.1% | 149,200 | $600K |
| Millennium Management | 0.00% | New | 137,911 | $554K |
| BlackRock, Inc. | 0.00% | No change | 72,669 | $292K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.5% | 69,919 | $281K |
| Apella Capital, LLC | 0.00% | Add +7.8% | 42,380 | $170K |
| Lion Point Capital, LP | 0.73% | New | 35,000 | $141K |
| State Street Corp. | 0.00% | Add +45.4% | 24,019 | $97K |
| Two Sigma Investments, LP | 0.00% | New | 22,294 | $90K |
| Morgan Stanley | 0.00% | Add +0.4% | 11,055 | $44K |
| Acadian Asset Management LLC | 0.00% | Reduce -39.3% | 10,579 | $42K |
| Royal Bank of Canada | 0.00% | Reduce -7.8% | 2,240 | $9K |
| UBS Group AG | 0.00% | Add +17970.0% | 1,807 | $7K |
| Deutsche Bank AG | 0.00% | New | 1,500 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -62.6% | 501 | $2K |
| Cwm, LLC | 0.00% | No change | 420 | $2K |
| Larson Financial Group LLC | 0.00% | New | 400 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +54.9% | 251 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 100 | $402 |
| BNP Paribas Financial Markets | 0.00% | No change | 62 | $249 |
| Bank of America Corp. | 0.00% | Add +2.0% | 51 | $205 |
"% of holder's portfolio" is NERV's weight in each manager's 13F, not the share of Minerva Neurosciences Inc. the manager owns.